PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
751
Travelers Companies
TRV
$61.3B
|
PN
Paul Newsome
| $272.33 | $310 |
14%
upside
| Overweight |
24 Jan ‘25
7 months ago |
|
|
UCB
752
United Community Banks, Inc.
UCB
$3.95B
|
SS
Stephen Scouten
| $32.54 | $35 |
8%
upside
| Neutral |
23 Jan ‘25
7 months ago |
|
753
FNB Corp
FNB
$5.88B
|
FS
Frank Schiraldi
| $16.38 | $18 |
10%
upside
| Overweight |
23 Jan ‘25
7 months ago |
|
|
DRUG
754
Bright Minds Biosciences
DRUG
$299M
|
YR
Yasmeen Rahimi
| $42.17 | $93 |
121%
upside
| Overweight |
23 Jan ‘25
7 months ago |
|
755
Peoples Bancorp
PEBO
$1.09B
|
NR
Nathan Race
| $30.43 | $40 |
31%
upside
| Overweight |
22 Jan ‘25
7 months ago |
|
756
Fifth Third Bancorp
FITB
$30.1B
|
SS
Scott Siefers
| $45.51 | $53 |
16%
upside
| Overweight |
22 Jan ‘25
7 months ago |
|
757
Huntington Bancshares
HBAN
$25.8B
|
SS
Scott Siefers
| $17.66 | $17 |
4%
downside
| Underweight |
21 Jan ‘25
7 months ago |
|
758
Keros Therapeutics
KROS
$636M
|
JC
Joseph Catanzaro
| $15.65 | $15 |
4%
downside
| Overweight |
17 Jan ‘25
7 months ago |
|
759
AirSculpt Technologies
AIRS
$381M
|
PK
Peter Keith
| $6.10 | $5 |
18%
downside
| Neutral |
17 Jan ‘25
7 months ago |
|
760
Teva Pharmaceuticals
TEVA
$22.4B
|
DA
David Amsellem
| $19.57 | $30 |
53%
upside
| Overweight |
17 Jan ‘25
7 months ago |
|
761
Utz Brands
UTZ
$1.12B
|
ML
Michael Lavery
| $13.02 | $20 |
54%
upside
| Overweight |
16 Jan ‘25
7 months ago |
|
762
Ultragenyx Pharmaceutical
RARE
$3.02B
|
CR
Christopher Raymond
| $31.29 | $140 |
347%
upside
| Overweight |
13 Jan ‘25
8 months ago |
|
763
LSB Industries
LXU
$585M
|
CN
Charles Neivert
| $8.13 | $11 |
35%
upside
| Overweight |
13 Jan ‘25
8 months ago |
|
|
AVDL
764
Avadel Pharmaceuticals
AVDL
$1.54B
|
DA
David Amsellem
| $15.81 | $13 |
18%
downside
| Overweight |
10 Jan ‘25
8 months ago |
|
765
Halozyme
HALO
$8.87B
|
JC
Joseph Catanzaro
| $75.80 | $53 |
30%
downside
| Neutral |
10 Jan ‘25
8 months ago |
|
766
Monopar Therapeutics
MNPR
$265M
|
CR
Christopher Raymond
| $42.90 | $72 |
68%
upside
| Overweight |
10 Jan ‘25
8 months ago |
|
767
Norwood Financial Corp
NWFL
$245M
|
FS
Frank Schiraldi
| $26.41 | $28 |
6%
upside
| Neutral |
8 Jan ‘25
8 months ago |
|
|
LAC
768
Lithium Americas
LAC
$677M
|
CN
Charles Neivert
| $2.80 | $3.50 |
25%
upside
| Neutral |
7 Jan ‘25
8 months ago |
|
|
MRX
769
Marex Group
MRX
$2.52B
|
PM
Patrick Moley
| $34.50 | $40 |
16%
upside
| Overweight |
7 Jan ‘25
8 months ago |
|
770
Planet Fitness
PLNT
$8.52B
|
PK
Peter Keith
| $101.48 | $123 |
21%
upside
| Overweight |
6 Jan ‘25
8 months ago |
|
771
Olaplex Holdings
OLPX
$941M
|
KW
Korinne Wolfmeyer
| $1.41 | $2 |
42%
upside
| Neutral |
6 Jan ‘25
8 months ago |
|
772
Varonis Systems
VRNS
$6.31B
|
RO
Rob Owens
| $56.32 | $50 |
11%
downside
| Neutral |
6 Jan ‘25
8 months ago |
|
773
Jamf
JAMF
$1.3B
|
RO
Rob Owens
| $9.78 | $23 |
135%
upside
| Overweight |
6 Jan ‘25
8 months ago |
|
774
Kearny Financial
KRNY
$415M
|
MF
Mark Fitzgibbon
| $6.61 | $8.50 |
29%
upside
| Overweight |
6 Jan ‘25
8 months ago |
|
775
Perrigo
PRGO
$3.04B
|
KW
Korinne Wolfmeyer
| $22.12 | $27 |
22%
upside
| Neutral |
6 Jan ‘25
8 months ago |
|